Head-to-head · Cost-Efficiency Index
HeliMeds vs Spry
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
HeliMeds
Shoppers who will pay a discounted 12-week lump sum upfront and understand the price resets higher on reorder.
Visit HeliMedsSpry
Shoppers who want compounded GLP-1 bundled with anti-aging peptides from one named founding team.
Visit SpryThe verdict
HeliMeds and Spry tie on the Cost-Efficiency Index at 67/100, so neither wins outright on the numbers. For most shoppers we'd start with HeliMeds (ranked #137, a hair above #140) — Shoppers who will pay a discounted 12-week lump sum upfront and understand the price resets higher on reorder. But Spry is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs HeliMeds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | HeliMeds | Spry |
|---|---|---|
| Cost-Efficiency Index | 67/100 | 67/100 |
| Semaglutide / mo | $99/mo (starting dose, 3-month plan, compounded) | $199/mo (all doses, compounded) |
| Tirzepatide / mo | $149/mo (starting dose, 3-month plan, compounded) | $299/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $2,388 |
| Tirzepatide / yr (modeled) | $1,788 | $3,588 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Yes |
| Rank here | #137 | #140 |
HeliMeds
67/100Where the value is
- Both compounded semaglutide and tirzepatide available, plus a brand Wegovy/Zepbound path on the same platform
- The heavily-discounted 12-week prepay plan is genuinely the cheapest entry point in this comparison set if a buyer can pay $297 or $447 upfront
- Wide state coverage — every US state except California and Alaska, per the site's own terms of service
The tradeoffs
- '$99/mo' and '$149/mo' are not subscription rates — they are a single upfront 12-week charge ($297/$447) divided by three, and the site explicitly says no recurring billing occurs
- Semaglutide reorders after the intro plan cost $239 for just a 4-week supply — nearly 2.5x the advertised headline rate
Spry
67/100Where the value is
- Real, named founding team with individual bios — confirmed live on the About page
- Pricing shown directly on the homepage and product pages, no sign-up wall required
- Explicitly describes its GLP-1s as compounded rather than leaving formulation ambiguous
The tradeoffs
- No dose-tier price breakdown is published for either drug
- No compounding pharmacy is named anywhere on the pages checked
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.